CA2228048A1 - Process for preparing solid dosage forms of very low-dose drugs - Google Patents
Process for preparing solid dosage forms of very low-dose drugs Download PDFInfo
- Publication number
- CA2228048A1 CA2228048A1 CA002228048A CA2228048A CA2228048A1 CA 2228048 A1 CA2228048 A1 CA 2228048A1 CA 002228048 A CA002228048 A CA 002228048A CA 2228048 A CA2228048 A CA 2228048A CA 2228048 A1 CA2228048 A1 CA 2228048A1
- Authority
- CA
- Canada
- Prior art keywords
- composition according
- drug
- alpha
- carrier
- daily dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 4
- 229940127021 low-dose drug Drugs 0.000 title description 7
- 239000007909 solid dosage form Substances 0.000 title description 6
- 239000003814 drug Substances 0.000 claims abstract description 55
- 229940079593 drug Drugs 0.000 claims abstract description 53
- 238000000034 method Methods 0.000 claims abstract description 48
- 239000000203 mixture Substances 0.000 claims abstract description 43
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 238000011321 prophylaxis Methods 0.000 claims abstract description 10
- 206010012289 Dementia Diseases 0.000 claims abstract description 8
- 239000002245 particle Substances 0.000 claims abstract description 8
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims abstract 18
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract 9
- 238000011282 treatment Methods 0.000 claims abstract 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract 5
- 239000013583 drug formulation Substances 0.000 claims abstract 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 11
- 239000011230 binding agent Substances 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 9
- WSVLPVUVIUVCRA-KPKNDVKVSA-N Alpha-lactose monohydrate Chemical compound O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O WSVLPVUVIUVCRA-KPKNDVKVSA-N 0.000 claims description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- 229960001021 lactose monohydrate Drugs 0.000 claims description 6
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 4
- 230000002378 acidificating effect Effects 0.000 claims description 4
- 238000009472 formulation Methods 0.000 claims description 4
- HWPKGOGLCKPRLZ-UHFFFAOYSA-M monosodium citrate Chemical compound [Na+].OC(=O)CC(O)(C([O-])=O)CC(O)=O HWPKGOGLCKPRLZ-UHFFFAOYSA-M 0.000 claims description 4
- 239000002524 monosodium citrate Substances 0.000 claims description 4
- 235000018342 monosodium citrate Nutrition 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- 239000000654 additive Substances 0.000 claims description 3
- 239000007884 disintegrant Substances 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 3
- 239000008119 colloidal silica Substances 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 2
- 229930195725 Mannitol Natural products 0.000 claims 2
- 229960004977 anhydrous lactose Drugs 0.000 claims 2
- 230000001419 dependent effect Effects 0.000 claims 2
- 239000000314 lubricant Substances 0.000 claims 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims 2
- 239000000594 mannitol Substances 0.000 claims 2
- 235000010355 mannitol Nutrition 0.000 claims 2
- 229960001855 mannitol Drugs 0.000 claims 2
- 235000019359 magnesium stearate Nutrition 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 238000001035 drying Methods 0.000 description 9
- 239000000843 powder Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 5
- 238000005507 spraying Methods 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- 229960001375 lactose Drugs 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 3
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 230000019771 cognition Effects 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000003801 milling Methods 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229940069328 povidone Drugs 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- PLFFHJWXOGYWPR-HEDMGYOXSA-N (4r)-4-[(3r,3as,5ar,5br,7as,11as,11br,13ar,13bs)-5a,5b,8,8,11a,13b-hexamethyl-1,2,3,3a,4,5,6,7,7a,9,10,11,11b,12,13,13a-hexadecahydrocyclopenta[a]chrysen-3-yl]pentan-1-ol Chemical compound C([C@]1(C)[C@H]2CC[C@H]34)CCC(C)(C)[C@@H]1CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@@H]1[C@@H](CCCO)C PLFFHJWXOGYWPR-HEDMGYOXSA-N 0.000 description 1
- 241000270878 Hyla Species 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 101100366940 Mus musculus Stom gene Proteins 0.000 description 1
- 235000011483 Ribes Nutrition 0.000 description 1
- 241000220483 Ribes Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 239000002535 acidifier Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007907 direct compression Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000000614 rib Anatomy 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 229940079832 sodium starch glycolate Drugs 0.000 description 1
- 239000008109 sodium starch glycolate Substances 0.000 description 1
- 229920003109 sodium starch glycolate Polymers 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9515624.6 | 1995-07-29 | ||
| GBGB9515624.6A GB9515624D0 (en) | 1995-07-29 | 1995-07-29 | Novel process |
| GBGB9606684.0A GB9606684D0 (en) | 1996-03-29 | 1996-03-29 | Novel process |
| GB9606684.0 | 1996-03-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2228048A1 true CA2228048A1 (en) | 1997-02-13 |
Family
ID=26307485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002228048A Abandoned CA2228048A1 (en) | 1995-07-29 | 1996-07-29 | Process for preparing solid dosage forms of very low-dose drugs |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0841902A2 (cs) |
| JP (1) | JPH11510493A (cs) |
| KR (1) | KR19990035972A (cs) |
| CN (1) | CN1196677A (cs) |
| AP (1) | AP858A (cs) |
| AR (1) | AR004178A1 (cs) |
| AU (1) | AU716961B2 (cs) |
| BG (1) | BG102266A (cs) |
| BR (1) | BR9609804A (cs) |
| CA (1) | CA2228048A1 (cs) |
| CZ (1) | CZ24798A3 (cs) |
| DZ (1) | DZ2077A1 (cs) |
| EA (2) | EA199901055A1 (cs) |
| HU (1) | HUP9900521A3 (cs) |
| IL (1) | IL122897A0 (cs) |
| MA (1) | MA23953A1 (cs) |
| MX (1) | MX9800809A (cs) |
| NO (1) | NO980384L (cs) |
| NZ (1) | NZ315632A (cs) |
| OA (1) | OA10659A (cs) |
| PL (1) | PL325242A1 (cs) |
| SK (1) | SK11098A3 (cs) |
| TR (1) | TR199800156T1 (cs) |
| UY (1) | UY24297A1 (cs) |
| WO (1) | WO1997004750A2 (cs) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9619074D0 (en) * | 1996-09-12 | 1996-10-23 | Smithkline Beecham Plc | Composition |
| JP2002506031A (ja) | 1998-03-11 | 2002-02-26 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 組成物 |
| FR2796840B1 (fr) * | 1999-07-26 | 2003-06-20 | Ethypharm Lab Prod Ethiques | Comprimes faiblement doses et procede de preparation |
| DE60139087D1 (de) | 2000-12-14 | 2009-08-06 | Ortho Mcneil Janssen Pharm | Verfahren zu Herstellung von Zubereitungen enthaltend einen Steroidhormon und ein Stabilisierungsmittel in nicht-kristallinen Form |
| WO2005097076A2 (en) * | 2004-04-09 | 2005-10-20 | Smithkline Beecham Corporation | Low dose pharmaceutical products |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4489026A (en) * | 1982-09-07 | 1984-12-18 | The Upjohn Company | Process for preparing solid unit dosage forms of ultra-low dose drugs |
| JPS5970614A (ja) * | 1982-10-14 | 1984-04-21 | Asahi Chem Ind Co Ltd | 微量主薬系湿式固形製剤方法 |
| US4898736A (en) * | 1988-03-09 | 1990-02-06 | Merck & Co., Inc. | Method for tablet preparation |
| ATE269330T1 (de) * | 1989-04-13 | 2004-07-15 | Beecham Group Plc | Chemische verbindungen |
| ZA939565B (en) * | 1993-12-21 | 1994-08-11 | Applied Analytical Ind Inc | Method for preparing low dose pharmaceutical products. |
-
1996
- 1996-07-25 AR ARP960103748A patent/AR004178A1/es not_active Application Discontinuation
- 1996-07-26 MA MA24329A patent/MA23953A1/fr unknown
- 1996-07-26 UY UY24297A patent/UY24297A1/es not_active IP Right Cessation
- 1996-07-27 DZ DZ960121A patent/DZ2077A1/fr active
- 1996-07-29 SK SK110-98A patent/SK11098A3/sk unknown
- 1996-07-29 PL PL96325242A patent/PL325242A1/xx unknown
- 1996-07-29 NZ NZ315632A patent/NZ315632A/xx unknown
- 1996-07-29 JP JP9507243A patent/JPH11510493A/ja active Pending
- 1996-07-29 MX MX9800809A patent/MX9800809A/es unknown
- 1996-07-29 CN CN96197054A patent/CN1196677A/zh active Pending
- 1996-07-29 EA EA199901055A patent/EA199901055A1/ru unknown
- 1996-07-29 WO PCT/EP1996/003326 patent/WO1997004750A2/en not_active Ceased
- 1996-07-29 AP APAP/P/1998/001170A patent/AP858A/en active
- 1996-07-29 AU AU67384/96A patent/AU716961B2/en not_active Ceased
- 1996-07-29 BR BR9609804A patent/BR9609804A/pt not_active Application Discontinuation
- 1996-07-29 CA CA002228048A patent/CA2228048A1/en not_active Abandoned
- 1996-07-29 KR KR1019980700633A patent/KR19990035972A/ko not_active Ceased
- 1996-07-29 EA EA199800179A patent/EA000740B1/ru not_active IP Right Cessation
- 1996-07-29 HU HU9900521A patent/HUP9900521A3/hu unknown
- 1996-07-29 TR TR1998/00156T patent/TR199800156T1/xx unknown
- 1996-07-29 IL IL12289796A patent/IL122897A0/xx unknown
- 1996-07-29 CZ CZ98247A patent/CZ24798A3/cs unknown
- 1996-07-29 EP EP96927621A patent/EP0841902A2/en not_active Withdrawn
-
1998
- 1998-01-28 OA OA9800013A patent/OA10659A/en unknown
- 1998-01-28 NO NO980384A patent/NO980384L/no unknown
- 1998-02-20 BG BG102266A patent/BG102266A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UY24297A1 (es) | 1997-01-23 |
| PL325242A1 (en) | 1998-07-06 |
| EA000740B1 (ru) | 2000-02-28 |
| AP858A (en) | 2000-07-12 |
| NO980384L (no) | 1998-03-26 |
| EA199800179A1 (ru) | 1998-10-29 |
| SK11098A3 (en) | 1998-07-08 |
| CZ24798A3 (cs) | 1998-06-17 |
| MA23953A1 (fr) | 1997-04-01 |
| OA10659A (en) | 2002-09-18 |
| WO1997004750A2 (en) | 1997-02-13 |
| MX9800809A (es) | 1998-04-30 |
| AP9801170A0 (en) | 1998-01-31 |
| KR19990035972A (ko) | 1999-05-25 |
| NZ315632A (en) | 1999-11-29 |
| HUP9900521A2 (hu) | 1999-06-28 |
| NO980384D0 (no) | 1998-01-28 |
| EA199901055A1 (ru) | 2000-06-26 |
| EP0841902A2 (en) | 1998-05-20 |
| AU6738496A (en) | 1997-02-26 |
| TR199800156T1 (xx) | 1998-04-21 |
| DZ2077A1 (fr) | 2002-07-22 |
| JPH11510493A (ja) | 1999-09-14 |
| AU716961B2 (en) | 2000-03-09 |
| HUP9900521A3 (en) | 2001-04-28 |
| BR9609804A (pt) | 1999-07-06 |
| IL122897A0 (en) | 1998-08-16 |
| AR004178A1 (es) | 1998-11-04 |
| BG102266A (en) | 1998-10-30 |
| CN1196677A (zh) | 1998-10-21 |
| WO1997004750A3 (en) | 1997-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA005803B1 (ru) | Новый препарат и форма для введения, включающие неустойчивое в кислой среде действующее вещество | |
| US8753682B2 (en) | Dual release oral tablet compositions of dexlansoprazole | |
| MX2007009571A (es) | Tabletas con dispersion mejorada de la sustancia del farmaco. | |
| TW202227072A (zh) | 生長抑制素(somatostatin)調節劑之調配物 | |
| UA124663C2 (uk) | Таблетка | |
| US20020150618A1 (en) | Process for preparing solid dosage forms of very low-dose drugs | |
| CZ20798A3 (cs) | Způsob přípravy chuťově korigovaných přípravků antibakteriálně účinných derivátů chinolonu | |
| CA2228048A1 (en) | Process for preparing solid dosage forms of very low-dose drugs | |
| AU2018341729A1 (en) | Pharmaceutical composition including multi-unit spheroidal tablet containing esomeprazole and spheroidal pharmaceutically acceptable salt thereof, and method of preparing the pharmaceutical composition | |
| JP2012140410A (ja) | ロキソプロフェンナトリウム及びトラネキサム酸を含有する固形製剤 | |
| KR20010061927A (ko) | 라소폭시펜의 투여요법 | |
| KR101492572B1 (ko) | 신규 약학 조성물 | |
| SK50132006A3 (sk) | Flukonazolové kapsuly so zlepšeným uvoľňovaním | |
| CA2275626C (en) | Homogeneous preformulations containing high concentrations of steroids, for producing low-dose solid and semi-solid pharmaceutical preparations | |
| US11878078B2 (en) | Instant release pharmaceutical preparation of anticoagulant and preparation method therefor | |
| MXPA98000809A (en) | Procedure to prepare forms of solid doses of very low dose of farm | |
| JP2000239185A (ja) | 医薬組成物 | |
| AU751607B2 (en) | Method of treatment of dementia | |
| AU2014202367B2 (en) | Novel pharmaceutical composition | |
| WO2025017072A1 (en) | Stable pharmaceutical compositions of a cyp11a1 inhibitor | |
| EP4026541A1 (en) | A film coated tablet of apixaban | |
| KR20090037946A (ko) | 장기간에 걸쳐 활성원을 방출하는 피하 이식제 | |
| WO2011055156A2 (en) | Pharmaceutical compositions with enhanced stability |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |